Shlomit Valenstein
Directeur des opérations chez HMT Medical Technologies Ltd.
Profil
Shlomit Valenstein currently works as a Chief Operating Officer at HMT Medical Technologies Ltd.
Postes actifs de Shlomit Valenstein
| Sociétés | Poste | Début |
|---|---|---|
HMT Medical Technologies Ltd.
 HMT Medical Technologies Ltd. Medical SpecialtiesHealth Technology HMT Medical Technologies Ltd. has developed a novel device called "The Splitter" to enable safer and more effective aortic valve replacement procedures. The need for The Splitter arises from the fact that 1.5 million people suffer from aortic stenosis, a complex disease caused by a narrowing or hardening of the aortic valve due to calcium buildup on the heart valve flaps. The Israeli company was founded in 2021 and operates with a highly skilled team in interventional cardiology, medical device development, and commercialization. The CEO is Shlomo Lewkowicz. | Directeur des opérations | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
HMT Medical Technologies Ltd.
HMT Medical Technologies Ltd. Medical SpecialtiesHealth Technology HMT Medical Technologies Ltd. has developed a novel device called "The Splitter" to enable safer and more effective aortic valve replacement procedures. The need for The Splitter arises from the fact that 1.5 million people suffer from aortic stenosis, a complex disease caused by a narrowing or hardening of the aortic valve due to calcium buildup on the heart valve flaps. The Israeli company was founded in 2021 and operates with a highly skilled team in interventional cardiology, medical device development, and commercialization. The CEO is Shlomo Lewkowicz. | Health Technology |
